| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
| COL1A1 |
P02452
|
collagen type I alpha 1 chain
|
|
1.00 |
0.430 |
0.808 |
| HBB |
P68871
|
hemoglobin subunit beta
|
|
1.2E-09 |
0.494 |
0.808 |
| STIM1 |
Q13586
|
stromal interaction molecule 1
|
|
0.78 |
0.501 |
0.808 |
| ITGA2B |
P08514
|
integrin subunit alpha 2b
|
|
1.5E-16 |
0.493 |
0.692 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
| PRDM16 |
Q9HAZ2
|
PR/SET domain 16
|
|
1.00 |
0.522 |
0.808 |
| GP1BB |
P13224
|
glycoprotein Ib platelet subunit beta
|
|
0.51 |
0.524 |
0.769 |
| XRCC2 |
O43543
|
X-ray repair cross complementing 2
|
|
4.0E-07 |
0.512 |
0.731 |
| THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
| PVR |
P15151
|
PVR cell adhesion molecule
|
|
3.9E-10 |
0.510 |
0.769 |
| CD9 |
P21926
|
CD9 molecule
|
|
4.7E-03 |
0.528 |
0.769 |
| FADS2 |
O95864
|
fatty acid desaturase 2
|
|
1.00 |
0.575 |
0.692 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |
| FADS1 |
O60427
|
fatty acid desaturase 1
|
|
0.37 |
0.582 |
0.769 |
| BAD |
Q92934
|
BCL2 associated agonist of cell death
|
|
4.6E-03 |
0.553 |
0.769 |
| CD226 |
Q15762
|
CD226 molecule
|
|
3.9E-02 |
0.548 |
0.769 |
| ST3GAL4 |
Q11206
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
4.0E-02 |
0.588 |
0.692 |
| ASAP1 |
Q9ULH1
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
|
|
1.00 |
0.556 |
0.808 |
| C4BPA |
P04003
|
complement component 4 binding protein alpha
|
|
0.46 |
0.556 |
0.846 |
| NECTIN2 |
Q92692
|
nectin cell adhesion molecule 2
|
|
0.97 |
0.575 |
0.769 |
| VAV1 |
P15498
|
vav guanine nucleotide exchange factor 1
|
|
1.00 |
0.556 |
0.769 |
| UMPS |
P11172
|
uridine monophosphate synthetase
|
|
1.1E-04 |
0.584 |
0.615 |